NanoCarrier Co., Ltd. (4571.T)
JPY 150.0
(-1.96%)
JPY 150.0
(-1.96%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -863 Million JPY | 17.15% |
| 2022 | -1.3 Billion JPY | 50.48% |
| 2021 | -2.05 Billion JPY | -934.42% |
| 2020 | -1.3 Billion JPY | 203.66% |
| 2019 | -1.1 Billion JPY | 86.2% |
| 2018 | -1.79 Billion JPY | 66.2% |
| 2017 | -5.32 Billion JPY | -97.77% |
| 2016 | -2.69 Billion JPY | -38.7% |
| 2015 | -2.05 Billion JPY | -80.24% |
| 2014 | -1.08 Billion JPY | 4.21% |
| 2013 | -1.11 Billion JPY | -134.33% |
| 2012 | -519.93 Million JPY | -64.18% |
| 2011 | -315.66 Million JPY | 42.79% |
| 2010 | -503.62 Million JPY | -5.05% |
| 2009 | -476.41 Million JPY | 7.99% |
| 2008 | -516.05 Million JPY | -18.28% |
| 2007 | -437.7 Million JPY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | -188.75 Million JPY | -6.79% |
| 2023 Q3 | -102.09 Million JPY | 51.75% |
| 2023 Q4 | -177.02 Million JPY | -73.4% |
| 2023 Q1 | -304.33 Million JPY | -502.05% |
| 2023 Q2 | -211.59 Million JPY | 30.47% |
| 2023 FY | - JPY | 17.15% |
| 2022 Q1 | -394 Million JPY | 27.96% |
| 2022 Q4 | 75.69 Million JPY | 110.72% |
| 2022 FY | - JPY | 50.48% |
| 2022 Q2 | -17.88 Million JPY | 95.46% |
| 2022 Q3 | -705.9 Million JPY | -3847.77% |
| 2021 Q3 | -478.79 Million JPY | 12.24% |
| 2021 Q4 | -546.91 Million JPY | -14.23% |
| 2021 Q2 | -545.58 Million JPY | -1.78% |
| 2021 Q1 | -536.03 Million JPY | -21.14% |
| 2021 FY | - JPY | -934.42% |
| 2020 FY | - JPY | 203.66% |
| 2020 Q2 | -296.47 Million JPY | -38.57% |
| 2020 Q3 | -349.86 Million JPY | -18.01% |
| 2020 Q4 | -442.5 Million JPY | -26.48% |
| 2020 Q1 | -213.95 Million JPY | -140.92% |
| 2019 Q1 | -593.63 Million JPY | -100.95% |
| 2019 Q4 | 522.8 Million JPY | 314.16% |
| 2019 FY | - JPY | 86.2% |
| 2019 Q2 | 70.76 Million JPY | 111.92% |
| 2019 Q3 | -244.12 Million JPY | -444.98% |
| 2018 FY | - JPY | 66.2% |
| 2018 Q4 | -295.41 Million JPY | 45.78% |
| 2018 Q3 | -544.83 Million JPY | -87.72% |
| 2018 Q1 | -641.44 Million JPY | -22.52% |
| 2018 Q2 | -290.23 Million JPY | 54.75% |
| 2017 Q3 | -2.63 Billion JPY | -221.62% |
| 2017 Q1 | -1.26 Billion JPY | -74.49% |
| 2017 FY | - JPY | -97.77% |
| 2017 Q4 | -523.53 Million JPY | 80.11% |
| 2017 Q2 | -818.5 Million JPY | 35.46% |
| 2016 Q2 | -661.41 Million JPY | -7.62% |
| 2016 Q1 | -614.59 Million JPY | -23.13% |
| 2016 Q4 | -726.77 Million JPY | -10.77% |
| 2016 Q3 | -656.09 Million JPY | 0.8% |
| 2016 FY | - JPY | -38.7% |
| 2015 Q3 | -509.09 Million JPY | -6.01% |
| 2015 Q1 | -441.47 Million JPY | -188.8% |
| 2015 Q4 | -499.12 Million JPY | 1.96% |
| 2015 Q2 | -480.23 Million JPY | -8.78% |
| 2015 FY | - JPY | -80.24% |
| 2014 Q1 | -381.7 Million JPY | -18.46% |
| 2014 FY | - JPY | 4.21% |
| 2014 Q4 | -152.86 Million JPY | 63.03% |
| 2014 Q3 | -413.43 Million JPY | -228.5% |
| 2014 Q2 | -125.85 Million JPY | 67.03% |
| 2013 FY | - JPY | -134.33% |
| 2013 Q2 | -223.84 Million JPY | 19.29% |
| 2013 Q3 | -283.33 Million JPY | -26.58% |
| 2013 Q4 | -322.21 Million JPY | -13.72% |
| 2013 Q1 | -277.35 Million JPY | -140.2% |
| 2012 FY | - JPY | -64.18% |
| 2012 Q3 | -94.8 Million JPY | -7.92% |
| 2012 Q2 | -87.84 Million JPY | 50.85% |
| 2012 Q4 | -115.46 Million JPY | -21.8% |
| 2012 Q1 | -178.74 Million JPY | -880.26% |
| 2011 Q4 | -18.23 Million JPY | 89.67% |
| 2011 Q1 | -153.49 Million JPY | -26.89% |
| 2011 FY | - JPY | 42.79% |
| 2011 Q3 | -176.45 Million JPY | -500.89% |
| 2011 Q2 | 44.01 Million JPY | 128.67% |
| 2010 Q1 | -141.33 Million JPY | -18.36% |
| 2010 Q4 | -120.97 Million JPY | -21.9% |
| 2010 Q3 | -99.23 Million JPY | 28.54% |
| 2010 Q2 | -138.87 Million JPY | 1.74% |
| 2010 FY | - JPY | -5.05% |
| 2009 Q2 | -120.26 Million JPY | 21.96% |
| 2009 Q3 | -82.62 Million JPY | 31.29% |
| 2009 FY | - JPY | 7.99% |
| 2009 Q4 | -119.4 Million JPY | -44.51% |
| 2009 Q1 | -154.09 Million JPY | -77.23% |
| 2008 Q3 | -145.22 Million JPY | 0.0% |
| 2008 Q4 | -86.94 Million JPY | 40.13% |
| 2008 FY | - JPY | -18.28% |
| 2007 FY | - JPY | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| KOHJIN BIO CO LTD | 958.1 Million JPY | 190.074% |
| PRISM BioLab Co.,LTD | -488.13 Million JPY | -76.796% |
| GNI Group Ltd. | 14.48 Billion JPY | 105.956% |
| Linical Co., Ltd. | 1.24 Billion JPY | 169.193% |
| Trans Genic Inc. | 240.95 Million JPY | 458.163% |
| MEDINET Co., Ltd. | -1.35 Billion JPY | 36.35% |
| Soiken Holdings Inc. | -583.2 Million JPY | -47.975% |
| Cytori Cell Research Institute, Inc. | -603.09 Million JPY | -43.096% |
| AnGes, Inc. | -8.86 Billion JPY | 90.26% |
| OncoTherapy Science, Inc. | -1.28 Billion JPY | 32.866% |
| Nxera Pharma Co., Ltd. | -7.39 Billion JPY | 88.336% |
| Immuno-Biological Laboratories Co., Ltd. | 128.1 Million JPY | 773.656% |
| Carna Biosciences, Inc. | -1.09 Billion JPY | 20.955% |
| CanBas Co., Ltd. | 53.65 Million JPY | 1708.544% |
| D. Western Therapeutics Institute, Inc. | -775.59 Million JPY | -11.27% |
| RaQualia Pharma Inc. | -111.8 Million JPY | -671.907% |
| Chiome Bioscience Inc. | -1.21 Billion JPY | 28.78% |
| Kidswell Bio Corporation | -1.38 Billion JPY | 37.501% |
| PeptiDream Inc. | 7.37 Billion JPY | 111.7% |
| Oncolys BioPharma Inc. | -1.92 Billion JPY | 55.278% |
| Ribomic Inc. | -1.01 Billion JPY | 14.768% |
| SanBio Company Limited | -4.52 Billion JPY | 80.928% |
| Healios K.K. | -3 Billion JPY | 71.3% |
| BrightPath Biotherapeutics Co., Ltd. | -1.16 Billion JPY | 25.973% |
| Kubota Pharmaceutical Holdings Co., Ltd. | -1.39 Billion JPY | 38.05% |
| Delta-Fly Pharma, Inc. | -1.4 Billion JPY | 38.445% |
| StemRIM | -2.03 Billion JPY | 57.53% |
| CellSource Co., Ltd. | 1.3 Billion JPY | 166.057% |
| FunPep Company Limited | -952 Million JPY | 9.349% |
| Kringle Pharma, Inc. | -888.76 Million JPY | 2.899% |
| Stella Pharma Corporation | -723.85 Million JPY | -19.223% |
| TMS Co., Ltd. | -937 Million JPY | 7.898% |
| Noile-Immune Biotech Inc. | -775.39 Million JPY | -11.299% |
| Cuorips Inc. | -518 Million JPY | -66.602% |
| K Pharma,Inc. | 366.05 Million JPY | 335.755% |
| Takara Bio Inc. | 8.02 Billion JPY | 110.755% |
| ReproCELL Incorporated | 8.24 Million JPY | 10566.95% |
| PhoenixBio Co., Ltd. | 87.93 Million JPY | 1081.373% |
| StemCell Institute Inc. | 534.35 Million JPY | 261.503% |
| Japan Tissue Engineering Co., Ltd. | 244.81 Million JPY | 452.513% |
| CellSeed Inc. | -836.51 Million JPY | -3.166% |